The Microbiome of Prostate Fluid Is Associated With Prostate CancerOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study characterized the bacterial community in prostatic fluid and asked whether it differs between men with and without prostate cancer. All participants had elevated prostate-specific antigen, so the aim was to find microbiome features that might aid diagnosis. Prostatic fluid was collected by prostate massage before biopsy. The V3-V4 region of the bacterial 16S ribosomal RNA gene was sequenced on an Illumina MiSeq. A random forest model was built to test diagnostic value.
Who was studied?
The study enrolled 59 men in Shanghai, China, all with PSA above 4 ng/ml before biopsy. Biopsy pathology classified 32 as prostate cancer patients and 27 as non-cancer controls. Mean age was about 68 in the cancer group and 65 in controls. Men with recent urinary or sexually transmitted infections, lower urinary tract symptoms, or antimicrobial exposure within four weeks were excluded. This was a human clinical cohort, not an animal model.
What were the most important findings?
Prostatic fluid from cancer patients showed significantly reduced microbial diversity, seen in lower Shannon and Simpson indices reflecting community evenness. Community richness by the Ace index did not differ between groups. No genus was unique to either group, but several genera differed significantly in abundance (P < 0.05). A random forest model using an 8-genus signature discriminated cancer status with an ROC area under the curve of 0.72.
What are the greatest implications of this study?
The findings support the existence of a prostate-specific microbiome and suggest its composition may relate to prostate cancer. Reduced diversity in cancer patients hints that resident bacteria could help maintain a stable prostatic microenvironment. The authors frame this as a pilot with a small sample and possible contamination from the urinary tract. The results identify candidate biomarkers for high-PSA men but do not establish that bacteria cause prostate cancer.